CRISPR and Cas Gene Market Size & Share 2023 to 2032
Market Size by Product & Services (Product {Kits & Enzymes, Antibodies, Libraries}, Services {Cell Line Engineering}), Application (Genome Engineering, Epigenetics), End Use, Global Forecast.
Report ID: GMI6286
|
Published Date: July 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
CRISPR and Cas Gene Market Size
CRISPR and Cas Gene Market size accounted for USD 2.5 billion in 2022 and is estimated to grow at 21.7% to reach USD 17.4 billion by 2032. As the prevalence of genetic diseases and complex medical conditions continues to rise, there is an increasing demand for innovative treatments that can target the root cause of these ailments.
CRISPR and Cas Gene Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
For instance, according to the Lancet Haematology report, in 2021, seaHaall-age prevalence of sickle cell disease among females and males was 3·9 million and 3·84 million respectively globally. By enabling precise and targeted modifications to DNA sequences, CRISPR allows researchers and pharmaceutical companies to develop customized gene therapy and precision medicine approaches.
CRISPR and Cas genes refer to gene-editing technologies used in molecular biology to modify DNA sequences with precision. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a naturally occurring genetic mechanism found in bacteria and archaea that acts as an adaptive immune system against viral infections. Whereas, cas (CRISPR-associated) genes encode for cas proteins, which function as molecular scissors, capable of cleaving specific DNA sequences.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the CRISPR and Cas gene market. The urgency to combat the pandemic had spurred scientists and researchers to explore innovative solutions. For instance, in March 2021, scientists from Nanyang Technological University in Singapore created a CRISPR-based coronavirus testing that produces findings in 30 minutes. The test checks the virus after it has mutated. Moreover, CRISPR technology has been leveraged in vaccine development, enabling the optimization of vaccine candidates, and facilitating more efficient vaccine production.
CRISPR and Cas Gene Market Trends
The increasing prevalence of cancer worldwide is anticipated to boost the industry evolution. For instance, according to the American Cancer Society, Inc. report, in 2022, there approximately more than 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. Therefore, CRISPR-Cas gene editing technology offers a promising approach in the fight against cancer by enabling precise and customizable alterations to the genetic makeup of cancer cells. Moreover, ongoing advancements in gene editing techniques and a deeper understanding of cancer genetics will accelerate the adoption of CRISPR technology.
CRISPR and Cas Gene Market Analysis
Off-target effects refer to unintended changes or mutations in the genome that occur when the CRISPR-Cas system mistakenly targets and edits DNA sequences other than the intended target. These unintended alterations may lead to potential safety concerns and unpredictability in gene editing outcomes, impacting the efficacy and reliability of CRISPR-based applications. Furthermore, the high cost associated with CRISPR technology may hamper its adoption, particularly in smaller research institutions and organizations with limited budgets.
By product & services, the CRISPR and Cas gene market is classified into product and services. The product segment accounted for 78.7% of the market share in 2022. The expanding range of applications for CRISPR technology, such as genome engineering, disease model studies, and functional genomics will accelerate the industry progression. Also, the increasing government and private spending for enhancement of innovative therapies along with growing adoption of strategic initiatives by industry players.
Based on application, the CRISPR and Cas gene market is segmented into cell line engineering, gRNA design, microbial gene editing, DNA synthesis, and screening. The genome engineering segment accounted for 38.5% of the market share in 2022 due to increasing genomics research and development activities demonstrating the effectiveness of CRISPR technologies. For instance, in May 2021, Vertex and CRISPR Therapeutics presented new clinical data on investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for severe hemoglobinopathies at the annual European Hematology Association Virtual Congress. CTX001 underwent evaluation in two active clinical trials, with the aim of potentially providing a one-time curative treatment for patients affected by transfusion-dependent thalassemia (TDT) and severe sickle cell disease (SCD).
Based on end-use, the CRISPR and Cas gene market is segmented into biotechnology & pharmaceutical companies, academics & government research institutes, and contract research organizations (CROs). The biotechnology & pharmaceutical companies segment is projected to witness lucrative growth of 21.2% by 2032. The growing number of partnerships and collaborations between academic researchers and industry players is expected to foster the adoption of CRISPR technology in the development of cutting-edge treatments and innovative solutions. Also, growing investment by biotechnology companies as well as employing gene modification for both research and commercial applications.
North America CRISPR and Cas gene market accounted for 42.3% market share in 2022. The region's strong biotechnology and pharmaceutical sector encourages research and development in CRISPR technology for drug discovery and therapeutics. Also, increasing government funding and research grants along with well-established healthcare infrastructure & favorable regulatory environment facilitate the adoption of CRISPR in clinical trials and therapeutic applications in the region.
CRISPR and Cas Gene Market Share
Major market players operating in the CRISPR and Cas gene market include
CRISPR and Cas Gene Industry News:
The CRISPR and Cas gene market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Products & Services
Application
End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →